InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Bell William F. Jr.. Director active across 1 company, notably PTC Therapeutics, INC.. In total, 2 filings have been logged. Activity tracked since 6 June 2023. The latest transaction was disclosed on 15 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations